foxo4-dri senolytic 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound Development of a novel senolytic
Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI Wikipedia Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI 2460055 10 9 AdooQ
Pay in 4 interest-free payments of $7.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



